Skip to main content
SpringerLink
Log in

Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in asthma

  • Drug and Profile Report
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1

References

  1. Lyseng-Williamson KA, Simpson D. Budesonide/formoterol pressurized metered-dose inhaler. Drugs 2008; 68(13): 1865–64

    Article  Google Scholar 

  2. Guidelines for the diagnosis and management of asthma: summary report 2007. Bethesda (MD): National Heart, Lung, and Blood Institute; 2007 Oct

  3. Symbicort® (budesonide and formoterol fumarate dihydrate) inhalation aerosol: US prescribing information. Wilmington (DE): AstraZeneca LP, 2009 Feb

  4. Remington TL, DiGiovine B. Long-acting β-agonists: anti-flammatory properties and synergy with corticosteroids in asthma. Curr Opin Pulm Med 2005 Jan; 11(1): 74–8

    Article  PubMed  Google Scholar 

  5. Hampel FC, Martin P, Mezzanotte S. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. J Asthma 2008 May; 45(4): 265–72

    Article  PubMed  CAS  Google Scholar 

  6. Corren J, Korenblat PE, Miller CJ, et al. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Clin Ther 2007 May; 29(5): 823–43

    Article  PubMed  CAS  Google Scholar 

  7. Noonan M, Rosenwasser LJ, Martin P, et al. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial [published erratum appears in Drugs 2007; 67 (5): 759]. Drugs 2006; 66(17): 2235–54

    Article  PubMed  CAS  Google Scholar 

  8. Murphy K, Nelson H, Parasuraman B, et al. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. Curr Med Res Opin 2008; 24(3): 879–94

    Article  PubMed  CAS  Google Scholar 

  9. Chervinsky P, Baker J, Bensch G, et al. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. Ann Allergy Asthma Immunol 2008 Nov; 101(5): 463–73

    Article  PubMed  CAS  Google Scholar 

  10. Peters SP, Premier BM, Mezzanotte WS, et al. Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. Allergy Asthma Proc 2008 Sep–Oct; 29(5): 499–516

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in asthma. Drugs Ther. Perspect 25, 1–4 (2009). https://doi.org/10.2165/0042310-200925110-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/0042310-200925110-00001

Search

Navigation